Daniel C Brennan Selected Research

thymoglobulin

11/2016	Differential risks for adverse outcomes 3 years after kidney transplantation based on initial immunosuppression regimen: a national study.
1/2010	Serum sickness after treatment with rabbit antithymocyte globulin in kidney transplant recipients with previous rabbit exposure.
5/2009	Rabbit antithymocyte globulin is more beneficial in standard kidney than in extended donor recipients.
10/2008	A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.
11/2006	Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
5/2006	Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience.
7/2004	Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel C Brennan Research Topics

Disease

18	Infections 09/2022 - 02/2005
10	Neoplasms (Cancer) 02/2021 - 04/2006
9	COVID-19 01/2022 - 01/2020
8	Delayed Graft Function 01/2020 - 11/2003
7	Hypertension (High Blood Pressure) 08/2021 - 04/2007
7	Chronic Kidney Failure (Chronic Renal Failure) 11/2020 - 04/2007
7	Diabetes Mellitus 06/2011 - 05/2003
6	Viremia 04/2017 - 03/2005
5	Cytomegalovirus Infections (Inclusion Disease) 02/2017 - 02/2003
5	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017 - 07/2004
4	Myocardial Infarction 01/2016 - 09/2004
4	Anemia 01/2013 - 10/2005
4	Obesity 01/2012 - 04/2007
3	Inflammation (Inflammations) 01/2021 - 01/2006
3	Pneumonia (Pneumonitis) 11/2016 - 08/2015
3	Sepsis (Septicemia) 11/2016 - 05/2015
3	Renal Insufficiency (Renal Failure) 02/2016 - 04/2009
3	Virus Diseases (Viral Diseases) 01/2016 - 04/2007
2	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 12/2011
2	Hemorrhage 01/2022 - 07/2014
2	Cognitive Dysfunction 10/2021 - 01/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021 - 01/2020
2	Frailty 01/2021 - 01/2019
2	Sclerosis 01/2019 - 01/2015
2	Proteinuria 01/2019 - 01/2015
2	Urinary Tract Infections (Urinary Tract Infection) 10/2017 - 02/2016
2	Hypotension (Low Blood Pressure) 01/2016 - 01/2015
2	Heart Arrest (Cardiac Arrest) 01/2016 - 01/2015
2	Death (Near-Death Experience) 04/2011 - 09/2004
2	Chronic Renal Insufficiency 08/2010 - 04/2009
2	Heart Failure 12/2009 - 10/2005
2	Iron Deficiencies 04/2009 - 01/2006
2	Peripheral Vascular Diseases (Peripheral Vascular Disease) 10/2005 - 02/2005
1	Coinfection 01/2022
1	Polycythemia (Erythrocytosis) 12/2021
1	Pulmonary Hypertension 08/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020
1	Chronic Disease (Chronic Diseases) 11/2020
1	Amyloidosis 05/2020
1	Hemolysis 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Transfusion Reaction 01/2020
1	Dementia (Dementias) 01/2020
1	Cysts 01/2020

Drug/Important Bio-Agent (IBA)

8	Tacrolimus (Prograf)FDA LinkGeneric 11/2016 - 03/2005
7	CreatinineIBA 01/2022 - 12/2011
7	thymoglobulin FDA Link 11/2016 - 07/2004
6	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2016 - 09/2002
5	SteroidsIBA 01/2020 - 01/2010
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
4	Antihypertensive Agents (Antihypertensives)IBA 08/2021 - 07/2005
4	Sirolimus (Rapamycin)FDA Link 11/2016 - 09/2002
3	Immunoglobulin G (IgG)IBA 01/2022 - 10/2008
3	Basiliximab FDA Link 01/2021 - 11/2006
3	Calcineurin InhibitorsIBA 01/2017 - 03/2005
3	DNA (Deoxyribonucleic Acid)IBA 02/2013 - 02/2003
3	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 10/2008 - 07/2004
2	Pharmaceutical PreparationsIBA 09/2022 - 06/2011
2	Immunoglobulin M (IgM)IBA 01/2022 - 01/2020
2	Cell-Free Nucleic AcidsIBA 05/2021 - 02/2021
2	Immune Checkpoint InhibitorsIBA 02/2021 - 01/2020
2	pembrolizumabIBA 02/2021 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 12/2015
2	Antiviral Agents (Antivirals)IBA 12/2020 - 04/2007
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2009
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2019 - 01/2015
2	Midodrine (Midon)FDA LinkGeneric 01/2018 - 01/2016
2	AntibodiesIBA 04/2017 - 12/2015
2	Prednisone (Sone)FDA LinkGeneric 11/2016 - 11/2006
2	TOR Serine-Threonine KinasesIBA 03/2013 - 06/2012
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 11/2006 - 01/2006
2	Azathioprine (Imuran)FDA LinkGeneric 01/2006 - 03/2005
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	remdesivirIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	SolutionsIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	C-Reactive ProteinIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 12/2020
1	Antimalarials (Antimalarial Agents)IBA 12/2020
1	Nucleic AcidsIBA 11/2020
1	Prealbumin (Transthyretin)IBA 05/2020
1	Radioisotopes (Radionuclides)IBA 05/2020
1	Apolipoprotein L1IBA 03/2020
1	Hemagglutinins (Hemagglutinin)IBA 01/2020

Therapy/Procedure

36	Kidney Transplantation 12/2021 - 09/2002
24	Transplantation 09/2022 - 11/2003
9	Therapeutics 01/2022 - 11/2006
5	Organ Transplantation 01/2020 - 02/2005
3	Nephrectomy 11/2020 - 06/2011
2	Length of Stay 01/2021 - 01/2018
2	Aftercare (After-Treatment) 11/2020 - 01/2010
2	Drug Therapy (Chemotherapy) 08/2010 - 04/2006
2	Islets of Langerhans Transplantation 09/2006 - 07/2004
1	Activities of Daily Living (ADL) 10/2021
1	Continuity of Patient Care 10/2021
1	Immunomodulation 02/2021
1	Critical Care (Surgical Intensive Care) 10/2020
1	Institutionalization (Institutionalized Persons) 01/2020
1	Donor Selection 01/2020